Endo Pharmaceuticals (ENDP)
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
Recs
JeremyBear
(< 20)
Submitted: 11/4/2009 2:41:46 PM :
Start Price:
$22.70
ENDP Score:
-5.36
eps acceleration&growth / value / recent price strength (4w)
Recs
Prodigy16
(81.52)
Submitted: 10/27/2009 4:47:51 PM :
Start Price:
$22.86
ENDP Score:
-5.98
Joel Greenblatt Pick
Recs
reddingrunner
(< 20)
Submitted: 10/12/2009 3:48:35 PM :
Start Price:
$23.98
ENDP Score:
-9.10
Screened some Magic Formula stocks through my brain and ended up with 10 new picks.
Recs
20PercentPM
(< 20)
Submitted: 10/3/2009 5:50:18 AM :
Start Price:
$23.38
ENDP Score:
-11.39
Stock has been under performing the market this year and is trading at a 33% PE discount to the specialty pharma group. Last weeks analyst upgrade should push the price higher.
Recs
wooderino
(89.98)
Submitted: 9/22/2009 1:36:08 PM :
Start Price:
$22.47
ENDP Score:
-3.40
strong 5 year ROE& profit margin improvement and still at reasonable PE ratios
Recs
cayamax
(< 20)
Submitted: 9/11/2009 11:11:43 AM :
Start Price:
$22.91
ENDP Score:
-7.63
An aging population will require lots of pain management.
Recs
LexTNZorro
(74.71)
Submitted: 9/5/2009 1:07:10 PM :
Start Price:
$22.62
ENDP Score:
-8.60
http://seekingalpha.com/article/159255-five-drug-makers-with-pending-catalysts?source=feed
Recs
jemsa
(82.75)
Submitted: 8/20/2009 2:28:27 PM :
Start Price:
$21.53
ENDP Score:
-6.04
caps 5, stockscouter10
Recs
HansHauge
(95.45)
Submitted: 8/3/2009 4:53:05 PM :
Start Price:
$21.11
ENDP Score:
-4.81
Magical Hat Equation
Recs
ZiggySTVSEP
(37.49)
Submitted: 7/27/2009 12:19:10 PM :
Start Price:
$20.10
ENDP Score:
-2.21
DFA50 APPRICIATED BY ABOUT 12% CAPS=5S
Recs
tortillatree
(84.31)
Submitted: 7/22/2009 10:03:39 AM :
Start Price:
$19.25
ENDP Score:
-0.46
Earnings are coming out in 9 days, and it won't look good because of all their acquisitions and research and court fees this quarter. Long term, it's still a buy, but I'm out for a few weeks. I'll get back in when things settle down.
Recs
KingKev
(74.21)
Submitted: 6/23/2009 1:29:31 PM :
Start Price:
$17.20
ENDP Score:
+6.11
generic's are going to be a major part of reducing healthcare costs
Recs
dmesq
(52.56)
Submitted: 6/13/2009 1:28:57 PM :
Start Price:
$17.64
ENDP Score:
+8.18
Baby boomers need meds, insurance carriers want generic. i bought this at 16.50.
Recs
MFBriguy
(99.78)
Submitted: 6/10/2009 4:18:42 PM :
Start Price:
$17.33
ENDP Score:
+11.19
Mgc Formula stock with 10/12 CAPShot. My testing of this screen so far has yielded some big winners (ghm, ctcm, qxm)
Recs
TMFBiologyFool
(93.17)
Submitted: 6/10/2009 3:47:57 PM :
Start Price:
$17.26
ENDP Score:
+11.15
Pain-free growth ahead.
Recs
DangerIsMidName
(56.99)
Submitted: 5/29/2009 9:50:28 PM :
Start Price:
$16.20
ENDP Score:
+18.99
Good financials. Seems cheap
Recs
scuby22
(77.91)
Submitted: 5/23/2009 9:30:15 PM :
Start Price:
$16.02
ENDP Score:
+13.41
As always, people will pay to stop pain. Why not pay less...especially if the government gets involved.
Recs
Teknowizz
(90.91)
Submitted: 5/16/2009 4:22:45 AM :
Start Price:
$16.01
ENDP Score:
+15.19
A recent pick by a CAPS Top-10 + C or better score in Navellier PG.
Recs
bfbfbf
(51.14)
Submitted: 5/3/2009 12:17:15 PM :
Start Price:
$16.60
ENDP Score:
+8.86
as long as people are in pain this type of company will survive. these guys are in a good position to do well with the health care reforms that are promised.
Recs
mm20001
(99.73)
Submitted: 4/30/2009 1:48:32 PM :
Start Price:
$18.17
ENDP Score:
-7.08
Mid cap value play. 780M cash vs. 470M debt, forward P/E 2010 is around 6, est. growth rate is 10% for next 5 years.
Recent earnings estimates:
CurrQtr NextQtr CurrYr NextYear
Mar-09 Jun-09 Dec-09 Dec-10
----------------------------------------------------------------------------------
Current 0.63 0.65 2.63 2.88
7 Days Ago 0.63 0.64 2.63 2.88
30 Days Ago 0.63 0.64 2.64 2.88
60 Days Ago 0.61 0.64 2.60 2.84
90 Days Ago 0.60 0.64 2.61 2.92
Actually beat the 0.63 est. for Mar-09 by 0.04, excluding the buyout costs for Indevus.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 54 1 2 3 Next »